Volume 5 Issue 3, Sep 2020

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 5 Issue 3, Sep 2020:
Letter
GSDME enhances Cisplatin sensitivity to regress non-small cell lung carcinoma by mediating pyroptosis to trigger antitumor immunocyte infiltration
Zhouyangfan Peng,Pengfei Wang,Wei Song,Qingmei Yao,Yinjia Li,Linglong Liu,Yapei Li &…Sufang Zhou